id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_oerhj4bfabhnvlfgtgfld6kaji	S. Amin	Sirolimus Ointment for Facial Angiofibromas in Individuals with Tuberous Sclerosis Complex	2017.0	7	.pdf	application/pdf	4694	578	67	Facial angiofibromas affect most patients with tuberous sclerosis complex. sirolimus ointment in 14 patients with TSC (9 children and 5 adults). photography, dermatological review using a validated Facial Angiofibroma Severity Index (FASI), and quality of life assessments Sirolimus ointment 0.1% administered once a day was effective in treating facial ointment for the treatment of facial angiofibromas, where different sirolimus ointment strength, preparation, and regimes We report our experience in using sirolimus ointment 0.1% for facial angiofibromas in children and adults with TSC, using a standardised assessed the effect of this treatment on quality of life. assessed the effect of this treatment on quality of life. severity of facial angiofibromas and treatment response. Table 1: Showing patients characteristics and Facial Angiofibroma Severity Index (FASI) score before and after treatment. patients, 1 had improvement in rash but no FASI score change. treatment on the quality of life of patients.	./cache/work_oerhj4bfabhnvlfgtgfld6kaji.pdf	./txt/work_oerhj4bfabhnvlfgtgfld6kaji.txt